Late-breaking Data: Congenital Ichthyosis Treatment Update
Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University in New Haven, CT, discusses findings from the phase 3 maximal use arm of the ASCEND Trial that looked at topical isotretinoin 0.05% (TMB-001) in congenital ichthyosis. The upshot? Topical isotretinoin, even when applied to 90% of a patient’s body surface area, showed […]